Fytexia Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 31
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Fytexia General Information

Description

Producer and supplier of natural ingredients intended to serve the international food supplement industry. The company specializes in offering polyphenols, a Mediterranean diet, natural ingredients, nutritional content polyphenols, antioxidants, nutraceuticals, sports nutrition and other products, helping the clients to reduce risk factors for non-communicable diseases by offering nutritional supplements from their scientific research and inspired by recognized public health food practices.

Contact Information

Website
www.fytexia.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other Consumer Non-Durables
Parent Company
ABF Ingredients
Primary Office
  • Zae Via Europa
  • 3 rue d Athenes
  • 34350 Vendres
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fytexia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fytexia‘s full profile, request access.

Request a free trial

Fytexia Patents

Fytexia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2686419-A1 Composition having lipolytic activity, production method thereof and use of the composition Abandoned 04-May-2007 000000000
US-20100166851-A1 Composition having lipolytic activity, production method thereof and use of the composition Abandoned 04-May-2007 000000000 0
JP-2010526043-A Compounds having lipolytic activity, methods for obtaining and using the same Abandoned 04-May-2007 000000000 0
EP-2146708-A1 Composition having lipolytic activity, production method thereof and use of the composition. Granted 04-May-2007 000000000
EP-2146708-B1 Composition having lipolytic activity, production method thereof and use of the composition. Active 04-May-2007 A61K36/73
To view Fytexia’s complete patent history, request access »

Fytexia Executive Team (4)

Name Title Board Seat Contact Info
Matthieu Arguillere Chief Executive Officer and President
Laurent Susini Administrative and Financial Director
You’re viewing 2 of 4 executive team members. Get the full list »

Fytexia Board Members (2)

Name Representing Role Since
00000 000000-000000 ArchiMed Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Fytexia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fytexia Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fytexia‘s full profile, request access.

Request a free trial